• Box Office

Attendance Climbs 25% in Brazil During First Half of 2023

Desapega!

The Brazilian cinema industry is showing signs of recovery as it approaches pre-pandemic audience numbers. In the first half of 2023, 55.6 million movie tickets were sold, a 25% increase compared to the same period last year. The box office revenue for this year also reached BRL 1.1 billion, a 26.4% rise from the first half of 2022. Despite the growth, the industry still has a way to go to match the record-breaking year of 2019 when 172.2 million tickets were sold, generating BRL 2.7 billion in revenue. he disparity between the percentage of the audience and box office revenue is partly due to higher ticket prices in 2023 compared to 2019.

However, the Brazilian film market is facing challenges in the national cinema sector. Brazilian productions accounted for only 1.01% of ticket sales and 0.81% of box office revenue in the first half of 2023. This is a decrease compared to the previous year, with domestic films representing over 6% of the market share. The most-watched Brazilian film so far is “Desapega!” with 150.5 thousand viewers.

In terms of the most watched movies to date in Brazil during 2023 are topped by “Super Mario Bros.” with 6.3 million viewers, “Fast and Furious X” at 5.9 million, “Puss in Boots 2” at 5.2 million, “Avatar: The Way of Water” with 4.8 million tickets sold.

The Brazilian box office has been showing positive growth compared to the North American market, with a 25% increase in audience and revenue in the first half of 2023, compared to a 20.8% increase in the US and Canada. The global box office numbers for the first semester are yet to be fully determined, but a report from Gower Street Analytics increased its forecast for the worldwide box office to $32 billion for 2023, a 23% growth compared to 2022. Ancine, the Brazilian National Film Agency, has launched an interactive dashboard called “Indicators of the Exhibition Market” to monitor important figures in the Brazilian cinema industry.

Source : Exibidor